Hospital
Memorial Health Care System INC.
Memorial Health Care System INC. was paid $4.08M by Medicaid between Jan 2018 and Dec 2024, across 132 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
33Billing provider infoMEMORIAL HEALTH CARE SYSTEM INC.
CHATTANOOGA, TN 37404
CHATTANOOGA, TN 37404
33aNPI1255428736assigned 10/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.08M
24GClaims312,186
24DCodes billed132
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#46 of 71
Median peer was paid$6.96M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,531 | $450K | |
| 2019 | 44,943 | $488K | |
| 2020 | 43,157 | $444K | |
| 2021 | 50,184 | $673K | |
| 2022 | 47,813 | $724K | |
| 2023 | 53,048 | $743K | |
| 2024incomplete | 30,510 | $555K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 11,171 | 8,817 | $1.02M |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 16% | 9,898 | 6,713 | $665K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.8% | 3,724 | 3,119 | $277K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.3% | 2,432 | 1,913 | $259K |
| G0378 | Hospital observation service, per hour | 4.4% | 2,058 | 1,287 | $180K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.4% | 12,205 | 8,486 | $178K |
| A0425 | Ground mileage, per statute mile | 3.3% | 23,516 | 13,127 | $136K |
| 71045 | Radiologic examination, chest; single view | 3.0% | 6,313 | 4,855 | $122K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 2.3% | 1,498 | 1,058 | $92K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 27,597 | 19,515 | $86K |
| 86480 | 2.0% | 1,245 | 1,157 | $84K | |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 1,420 | 1,167 | $73K |
120 more codes
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 1.5% | 11,111 | $60K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 1,395 | $59K |
| 80053 | Comprehensive metabolic panel | 1.4% | 12,723 | $56K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.2% | 3,144 | $49K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.2% | 34,800 | $48K |
| 84484 | 1.1% | 6,273 | $45K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 2,584 | $41K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 10,189 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,188 | $30K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 808 | $30K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 331 | $25K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,239 | $23K |
| 99218 | <1% | 214 | $23K | |
| 83880 | <1% | 1,095 | $22K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,391 | $19K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,081 | $18K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 764 | $18K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 657 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,478 | $16K |
| 83735 | <1% | 5,738 | $15K | |
| 85730 | <1% | 4,461 | $14K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 111 | $13K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 428 | $13K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 498 | $13K |
| 84703 | <1% | 2,284 | $11K | |
| 83690 | <1% | 2,528 | $11K | |
| 85610 | <1% | 5,782 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,379 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 245 | $10K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 419 | $10K |
| 80061 | Lipid panel | <1% | 3,541 | $9K |
| 93017 | <1% | 239 | $7K | |
| 81001 | <1% | 5,798 | $7K | |
| 87040 | <1% | 1,192 | $6K | |
| 82962 | <1% | 5,246 | $6K | |
| 83605 | <1% | 1,228 | $6K | |
| 87631 | <1% | 306 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,420 | $6K |
| 87077 | <1% | 1,976 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,366 | $6K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 654 | $5K |
| 87186 | <1% | 1,341 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,481 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,094 | $4K |
| 84439 | <1% | 1,685 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 54 | $3K |
| 87088 | <1% | 1,249 | $3K | |
| 85027 | <1% | 1,542 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 158 | $3K |
| 83655 | <1% | 1,336 | $3K | |
| 82607 | <1% | 525 | $3K | |
| 96376 | <1% | 493 | $2K | |
| 87070 | <1% | 693 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 430 | $2K |
| 71250 | <1% | 25 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 14 | $2K |
| 82947 | <1% | 1,188 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,278 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,678 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 256 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,324 | $1K |
| 77080 | <1% | 12 | $1K | |
| 85014 | <1% | 1,145 | $977.57 | |
| 86140 | <1% | 570 | $846.30 | |
| 80050 | General health panel | <1% | 257 | $816.28 |
| 80076 | <1% | 217 | $773.56 | |
| 71271 | <1% | 27 | $746.40 | |
| 85018 | <1% | 941 | $697.91 | |
| 82565 | <1% | 284 | $639.38 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 14 | $627.97 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | <1% | 17 | $559.36 |
| 87205 | <1% | 337 | $533.27 | |
| 84145 | <1% | 548 | $525.06 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,245 | $433.59 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 29 | $432.64 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,317 | $428.05 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,842 | $404.52 |
| 87081 | <1% | 237 | $393.20 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,176 | $330.08 |
| 85652 | <1% | 460 | $328.08 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 825 | $325.65 |
| 82043 | <1% | 119 | $274.04 | |
| 82746 | <1% | 67 | $231.20 | |
| 82728 | <1% | 82 | $231.04 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 617 | $225.19 |
| 83540 | <1% | 157 | $217.23 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,727 | $189.87 |
| 86850 | <1% | 28 | $162.64 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,318 | $122.11 |
| 82550 | <1% | 56 | $118.53 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 50 | $112.20 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 340 | $104.07 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 142 | $97.48 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,017 | $95.18 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 226 | $81.68 |
| C1769 | Guide wire | <1% | 289 | $66.46 |
| J1815 | Injection, insulin, per 5 units | <1% | 312 | $57.97 |
| 83550 | <1% | 33 | $50.52 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 585 | $46.31 |
| 87252 | <1% | 27 | $45.10 | |
| 76937 | <1% | 15 | $37.28 | |
| 86038 | <1% | 13 | $26.44 | |
| 86901 | <1% | 28 | $25.40 | |
| 86039 | <1% | 13 | $21.64 | |
| 93356 | <1% | 14 | $19.97 | |
| 86900 | <1% | 28 | $14.77 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $12.72 |
| J7999 | Compounded drug, not otherwise classified | <1% | 149 | $9.14 |
| 84132 | <1% | 15 | $6.92 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 13 | $3.67 |
| A9270 | Non-covered item or service | 0% | 5,621 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 84 | $0.00 |
| 88342 | 0% | 15 | $0.00 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 41 | $0.00 |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 0% | 49 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 38 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 42 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 47 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 14 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSUTTON, MICHAEL (VICE PRESIDENT, FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Memorial Health Care System INC. | Hixson, TN | $2.38M |
| Philip R. Mill, Od and Michael D. Sutton, Od INC. | Pittsburg, CA | $420K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.